NCT04982848 2025-11-18Korea Post Marketing Surveillance (PMS) Study of Talzenna®PfizerNot yet recruiting600 enrolled
NCT05141708 2024-02-16Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2mPfizerCompleted33 enrolled 9 charts
NCT04987931 2024-01-22Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast CancerPfizerCompleted84 enrolled 11 charts